Key result
Perioperative statin therapy reduces mortality rates by up to 59% after vascular surgery, while postoperative statin withdrawal significantly increases the risk of adverse cardiac events.
Why the study?
Does statin therapy during the perioperative period reduce mortality and cardiac morbidity in patients undergoing surgery?
Population
Patients undergoing major vascular, cardiac, or noncardiac surgery
Comparison
Statin therapy during the perioperative period vs No statin therapy or statin withdrawal
Design
Review
Authors
Loading...
May support statin continuation perioperatively in vascular surgery; leaves open confirmation by RCTs.
Does statin therapy during the perioperative period reduce mortality and cardiac morbidity in patients undergoing surgery?
Perioperative statin therapy appears to significantly reduce postoperative mortality and cardiac morbidity, likely due to pleiotropic anti-inflammatory and antithrombotic effects, though adequately powered randomized controlled trials are required to confirm these observational findings.
Manach et al. (2008) conducted a review in Patients undergoing surgery in the perioperative period. Perioperative statin therapy vs. No statin therapy or statin withdrawal was evaluated. Perioperative statin therapy reduces mortality rates by up to 59% after vascular surgery, while postoperative statin withdrawal significantly increases the risk of adverse cardiac events.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: